Elevated MAT2A and SAM levels are observed in murine colon cancer models and polyps, where growth factors (EGF, IGF-1, leptin) upregulate MAT2A to promote CRC cell growth (178). This evidence concerns the gene MAT2A and colorectal carcinoma.